Genetic and Pharmacological Inactivation of ANGPTL3 is Associated With Reduced Atherosclerotic Cardiovascular Disease

被引：0
|
作者：
Dewey, Frederick E.
Gusarova, Viktoria
O'Dushlaine, Colm
Gottesman, Omri
Van Hout, Cristopher V.
Bruse, Shannon
Leader, Joseph B.
Murray, Michael F.
Ritchie, Marylyn D.
Kirchner, H. Lester
Ledbetter, David H.
Habegger, Lukas
Zhao, An
Shao, Weiping
Overton, John
Reid, Jeffrey
Stahl, Neil
Murphy, Andrew
Banerjee, Poulabi
Mellis, Scott
Sasiela, William J.
Carey, David J.
van den Hoek, Anita M.
Princen, Hans M.
Borecki, Ingrid B.
Shuldiner, Alan R.
Yancopoulos, George D.
Gromada, Jesper
Baras, Aris
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Genetics; Gene mutations; Lipids; Atherosclerosis; Coronary artery disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16563
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
    Dewey, F. E.
    Gusarova, V.
    Dunbar, R. L.
    O'Dushlaine, C.
    Schurmann, C.
    Gottesman, O.
    McCarthy, S.
    Van Hout, C. V.
    Bruse, S.
    Dansky, H. M.
    Leader, J. B.
    Murray, M. F.
    Ritchie, M. D.
    Kirchner, H. L.
    Habegger, L.
    Lopez, A.
    Penn, J.
    Zhao, A.
    Shao, W.
    Stahl, N.
    Murphy, A. J.
    Hamon, S.
    Bouzelmat, A.
    Zhang, R.
    Shumel, B.
    Pordy, R.
    Gipe, D.
    Herman, G. A.
    Sheu, W. H. H.
    Lee, I-T.
    Liang, K. -W.
    Guo, X.
    Rotter, J. I.
    Chen, Y. -D. I.
    Kraus, W. E.
    Shah, S. H.
    Damrauer, S.
    Small, A.
    Rader, D. J.
    Wulff, A. B.
    Nordestgaard, B. G.
    Tybjaerg-Hansen, A.
    van den Hoek, A. M.
    Princen, H. M. G.
    Ledbetter, D. H.
    Carey, D. J.
    Overton, J. D.
    Reid, J. G.
    Sasiela, W. J.
    Banerjee, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03): : 211 - 221
  • [2] Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
    Chan, Dick C.
    Watts, Gerald F.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 27 (01)
  • [3] ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
    Luo, Fei
    Das, Avash
    Khetarpal, Sumeet A.
    Fang, Zhenfei
    Zelniker, Thomas A.
    Rosenson, Robert S.
    Qamar, Arman
    TRENDS IN CARDIOVASCULAR MEDICINE, 2024, 34 (04) : 215 - 222
  • [4] Concerns on the Genetic or Therapeutic Antagonism of ANGPTL3
    Luo, Fei
    Guo, Yuan
    Fang, Zhenfei
    Li, Xiangping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : 2099 - 2099
  • [5] ANGPTL3 PLASMA LEVELS AND GENETIC VARIANTS
    Tikka, Anna
    ATHEROSCLEROSIS, 2017, 263 : E205 - E205
  • [6] Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation
    Athyros, Vasilios G.
    Katsiki, Niki
    Dimakopoulou, Aikaterini
    Patoulias, Dimitrios
    Alataki, Sofia
    Doumas, Michael
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (31) : 3638 - 3646
  • [7] Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
    Graham, Mark J.
    Lee, Richard G.
    Brandt, Teresa A.
    Tai, Li-jung
    Fu, Wuxia
    Peralta, Raechel
    Yu, Rosie
    Hurh, Eunju
    Paz, Erika
    McEvoy, Bradley W.
    Baker, Brenda F.
    Pham, Nguyen C.
    Digenio, Andres
    Hughes, Steven G.
    Geary, Richard S.
    Witztum, Joseph L.
    Crooke, Rosanne M.
    Tsimikas, Sotirios
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03): : 222 - 232
  • [8] ANGPTL3 associated with renal disease and puromycin induced podocyte damage
    Jia, R.
    Hong, X.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1595 - 1595
  • [9] Association of Genotypes of ANGPTL3 with Vitamin D and Calcium Concentration in Cardiovascular Disease
    Aghasizadeh, Malihe
    Ghanei, Mahmoud
    Ghoflchi, Sahar
    Asadian-sohan, Parisa
    Haghani, Mohammad
    Kazemi, Tooba
    Esmaily, Habibollah
    Avan, Amir
    Ferns, Gordon A.
    Miri-Moghaddam, Ebrahim
    Ghayour-Mobarhan, Majid
    BIOCHEMICAL GENETICS, 2023, 62 (4) : 2482 - 2494
  • [10] ANGPTL3 Inhibitors - Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism -
    Geladari, Eleni
    Tsamadia, Panagiota
    Vallianou, Natalia G.
    CIRCULATION JOURNAL, 2019, 83 (02) : 267 - 273
12345